Medirom Healthcare [MRM] vs Medifast [MED] Detailed Stock Comparison

Medirom Healthcare Technologies Inc.

NASDAQ
Loading...

Medifast Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Medirom Healthcare Technologies Inc. wins in 11 metrics, Medifast Inc. wins in 6 metrics, with 0 ties. Medirom Healthcare Technologies Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Medirom Healthcare Technologies Inc. Medifast Inc. Better
P/E Ratio (TTM) 3.09 531.50 Medirom Healthcare Technologies Inc.
Price-to-Book Ratio 5.92 0.57 Medifast Inc.
Debt-to-Equity Ratio 786.42 5.38 Medifast Inc.
PEG Ratio N/A -0.22 N/A
EV/EBITDA 27.84 -1,469.18 Medirom Healthcare Technologies Inc.
Profit Margin (TTM) 0.50% -4.84% Medirom Healthcare Technologies Inc.
Operating Margin (TTM) -25.84% -10.39% Medifast Inc.
Return on Equity 53.19% -9.13% Medirom Healthcare Technologies Inc.
Return on Assets (TTM) -1.78% -3.34% Medirom Healthcare Technologies Inc.
Free Cash Flow (TTM) $-1.90B $1.25M Medifast Inc.
1-Year Return -26.45% -10.95% Medifast Inc.
Price-to-Sales Ratio (TTM) 0.00 0.32 Medirom Healthcare Technologies Inc.
Enterprise Value $25.99M $-42.61M Medirom Healthcare Technologies Inc.
EV/Revenue Ratio 0.51 -0.11 Medirom Healthcare Technologies Inc.
Gross Profit Margin (TTM) N/A 69.43% N/A
Revenue per Share (TTM) $1,222 $35 Medirom Healthcare Technologies Inc.
Earnings per Share (Diluted) $0.37 $-1.70 Medirom Healthcare Technologies Inc.
Beta (Stock Volatility) 1.07 0.56 Medifast Inc.
Short % of Float 1.55% 19.31% Medirom Healthcare Technologies Inc.

Medirom Healthcare Technologies Inc. vs Medifast Inc. Stock Performance Analysis

Loading Price Chart...

MRM
MED

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Medirom Healthcare Technologies Inc.0.00%-0.83%-2.46%-9.16%-44.13%-39.29%
Medifast Inc.0.25%-6.69%15.43%14.57%12.98%17.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Medirom Healthcare Technologies Inc.-26.45%-81.00%-89.30%-92.08%-92.08%-92.08%
Medifast Inc.-10.95%-85.01%-95.99%-61.95%-51.02%-36.36%

Performance & Financial Health Analysis: Medirom Healthcare Technologies Inc. vs Medifast Inc.

MetricMRMMED
Market Information
Market Cap i$9.25M$121.13M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i33,787240,387
90 Day Avg. Volume i25,639275,592
Last Close$1.19$12.27
52 Week Range$0.90 - $4.45$9.22 - $15.46
% from 52W High-73.26%-20.63%
All-Time High$19.80 (Dec 28, 2020)$336.99 (May 24, 2021)
% from All-Time High-93.99%-96.36%
Growth Metrics
Quarterly Revenue Growth-0.07%-0.37%
Quarterly Earnings GrowthN/A-0.37%
Financial Health
Profit Margin (TTM) i0.01%-0.05%
Operating Margin (TTM) i-0.26%-0.10%
Return on Equity (TTM) i0.53%-0.09%
Debt to Equity (MRQ) i786.425.38
Cash & Liquidity
Book Value per Share (MRQ)$0.19$19.29
Cash per Share (MRQ)$4.13$16.22
Operating Cash Flow (TTM) i$-5,623,917$6.86M
Levered Free Cash Flow (TTM) i$1.96M$5.41M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A$0.00

Valuation & Enterprise Metrics Analysis: Medirom Healthcare Technologies Inc. vs Medifast Inc.

MetricMRM (Apr 26, 2026)MED (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i3.09531.50
Forward P/E iN/A-4.00
PEG Ratio iN/A-0.22
Price to Sales (TTM) i0.000.32
Price to Book (MRQ) i5.920.57
Market Capitalization
Market Capitalization i$9.25M$121.13M
Enterprise Value i$25.99M$-42,606,284
Enterprise Value Metrics
Enterprise to Revenue i0.51-0.11
Enterprise to EBITDA i27.84-1,469.18
Risk & Other Metrics
Beta i1.070.56
Book Value per Share (MRQ) i$0.19$19.29

Financial Statements Comparison: Medirom Healthcare Technologies Inc. vs Medifast Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricMRM (2024)MED (2025)
Revenue/Sales i8.30B385.79M
Cost of Goods Sold i6.05B110.60M
COGS % of Revenue i72.9%28.7%
Gross Profit i2.25B275.19M
Gross Margin i27.1%71.3%
Research & Development iN/AN/A
Operating Income (EBIT) i18.63M-14.21M
Operating Margin i0.2%-3.7%
EBITDA i351.61M29,000
EBITDA Margin i4.2%0.0%
Pre-Tax Income i47.71M-5.64M
Pre-Tax Income % of Revenue i0.6%-1.5%
Income Tax i-90.48M13.03M
Income Tax % of Revenue i-1.1%3.4%
Net Income (Profit) i138.19M-18.67M
Profit Margin i1.7%-4.8%

Balance Sheet & Liquidity Metrics

MetricMRM (2024)MED (2025)
Cash & Equivalents i329.40M89.30M
Total Current Assets i2.71B201.68M
Total Current Assets % of Revenue i32.6%52.3%
Total Current Liabilities i4.18B42.96M
Total Current Liabilities % of Revenue i50.4%11.1%
Long-Term Debt i2.05BN/A
Long-Term Debt % of Revenue i24.7%0.0%
Total Shareholders Equity i1.19B198.92M
Retained Earnings i229.04M158.27M
Retained Earnings % of Revenue i2.8%41.0%
Property, Plant & Equipment i2.07B7.23M

Cash Flow Statement Comparison

MetricMRM (2024)MED (2025)
Operating Cash Flow i1.28B8.92M
Operating Cash Flow % of Revenue i15.4%2.3%
Capital Expenditures i-71.41M-5.61M
Free Cash Flow i-1.90B1.25M
FCF Margin i-22.9%0.3%
Debt Repayment i-685.04MN/A
Common Stock Repurchase iN/A-369,000

Short Interest & Institutional Ownership Analysis

MetricMRMMED
Shares Short i101,1292.06M
Short Ratio i2.007.14
Short % of Float i1.55%19.31%
Shares Outstanding i7.90M10.99M
Float Shares i5.82M8.48M
% Held by Insiders i26.42%3.86%
% Held by Institutions i0.18%78.14%
% Held by Public i73.40%18.00%

Dividend Analysis & Yield Comparison: Medirom Healthcare Technologies Inc. vs Medifast Inc.

MetricMRMMED
Last 12-Month Dividend iN/A$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A$2.74
3-Year Avg Dividend Yield iN/A1.43%
3-Year Total Dividends iN/A$8.22
Ex-Dividend DateN/AJun 26, 2023